APO Research
Talk to an analyst

APO RESEARCH · REPORT

IL-23 Receptor Antagonist

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global IL-23 Receptor Antagonist Industry Growth and Trends Forecast to 2032

27 December 2025117 pages

Choose your research edition.

Industry ResearchIL-23 Receptor Antagonist Industry Research Report 2026135 pages · $2,950 USDIndustry Growth & TrendsGlobal IL-23 Receptor Antagonist Industry Growth and Trends Forecast to 2032117 pages · $3,450 USDMarket StructureGlobal IL-23 Receptor Antagonist Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal IL-23 Receptor Antagonist Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal IL-23 Receptor Antagonist Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global IL-23 Receptor Antagonist market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for IL-23 Receptor Antagonist is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for IL-23 Receptor Antagonist is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for IL-23 Receptor Antagonist is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of IL-23 Receptor Antagonist include Qyuns Therapeutics, China Medical System, Huadong Medicine, Bio-Thera Solutions, Teva, Sun Pharma, Sandoz, Samsung Bioepis and Janssen Pharmaceuticals, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global IL-23 Receptor Antagonist market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The IL-23 Receptor Antagonist market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global IL-23 Receptor Antagonist market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to IL-23 Receptor Antagonist.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global IL-23 Receptor Antagonist market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

IL-23 Receptor Antagonist Market by Company

Qyuns Therapeutics

China Medical System

Huadong Medicine

Bio-Thera Solutions

Teva

Sun Pharma

Sandoz

Samsung Bioepis

Janssen Pharmaceuticals

Eli Lilly

Celltrion

Biocon Biologics

Amgen

Almirall

AbbVie Biotechnology

IL-23 Receptor Antagonist Segment by Type

Briakinumab

Guselkumab

Mirikizumab

Risankizumab

Tildrakizumab

Ustekinumab

Other

IL-23 Receptor Antagonist Segment by Application

Plaque Psoriasis

Crohn's Disease

Psoriatic Arthritis

Other

IL-23 Receptor Antagonist Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global IL-23 Receptor Antagonist market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of IL-23 Receptor Antagonist and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of IL-23 Receptor Antagonist.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of IL-23 Receptor Antagonist manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of IL-23 Receptor Antagonist in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Briakinumab Table 2. Major Company of Guselkumab Table 3. Major Company of Mirikizumab Table 4. Major Company of Risankizumab Table 5. Major Company of Tildrakizumab Table 6. Major Company of Ustekinumab Table 7. Major Company of Other Table 8. Global IL-23 Receptor Antagonist Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 9. Global IL-23 Receptor Antagonist Sales by Type (2021-2026) & (K Units) Table 10. Global IL-23 Receptor Antagonist Sales Market Share in Volume by Type (2021-2026) Table 11. Global IL-23 Receptor Antagonist Sales by Type (2021-2026) & (US$ Million) Table 12. Global IL-23 Receptor Antagonist Sales Market Share in Value by Type (2021-2026) Table 13. Global IL-23 Receptor Antagonist Price by Type (2021-2026) & (US$/Unit) Table 14. Global IL-23 Receptor Antagonist Sales by Type (2027-2032) & (K Units) Table 15. Global IL-23 Receptor Antagonist Sales Market Share in Volume by Type (2027-2032) Table 16. Global IL-23 Receptor Antagonist Sales by Type (2027-2032) & (US$ Million) Table 17. Global IL-23 Receptor Antagonist Sales Market Share in Value by Type (2027-2032) Table 18. Global IL-23 Receptor Antagonist Price by Type (2027-2032) & (US$/Unit) Table 19. North America IL-23 Receptor Antagonist Sales by Type (2021-2026) & (K Units) Table 20. North America IL-23 Receptor Antagonist Sales by Type (2021-2026) & (US$ Million) Table 21. Europe IL-23 Receptor Antagonist Sales by Type (2021-2026) & (K Units) Table 22. Europe IL-23 Receptor Antagonist Sales by Type (2021-2026) & (US$ Million) Table 23. Asia-Pacific IL-23 Receptor Antagonist Sales by Type (2021-2026) & (K Units) Table 24. Asia-Pacific IL-23 Receptor Antagonist Sales by Type (2021-2026) & (US$ Million) Table 25. Latin America IL-23 Receptor Antagonist Sales by Type (2021-2026) & (K Units) Table 26. Latin America IL-23 Receptor Antagonist Sales by Type (2021-2026) & (US$ Million) Table 27. Middle East and Africa IL-23 Receptor Antagonist Sales by Type (2021-2026) & (K Units) Table 28. Middle East and Africa IL-23 Receptor Antagonist Sales by Type (2021-2026) & (US$ Million) Table 29. IL-23 Receptor Antagonist Industry Trends Table 30. IL-23 Receptor Antagonist Industry Drivers Table 31. IL-23 Receptor Antagonist Industry Opportunities and Challenges Table 32. IL-23 Receptor Antagonist Industry Restraints Table 33. Global IL-23 Receptor Antagonist Sales Revenue by Company (US$ Million) & (2021-2026) Table 34. Global IL-23 Receptor Antagonist Revenue Market Share by Company (2021-2026) Table 35. Global IL-23 Receptor Antagonist Sales by Company (2021-2026) & (K Units) Table 36. Global IL-23 Receptor Antagonist Sales Share by Company (2021-2026) Table 37. Global IL-23 Receptor Antagonist Market Price by Company (2021-2026) & (US$/Unit) Table 38. Global IL-23 Receptor Antagonist Industry Company Ranking, 2024 VS 2025 VS 2026 Table 39. Global IL-23 Receptor Antagonist Major Company Production Sites and Headquarters Table 40. Global IL-23 Receptor Antagonist Company, Product Type & Application Table 41. Global IL-23 Receptor Antagonist Company Establishment Date Table 42. Global Company Market Concentration Ratio (CR5 and HHI) Table 43. Global IL-23 Receptor Antagonist by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 44. Global IL-23 Receptor Antagonist Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 45. Global IL-23 Receptor Antagonist Sales by Region (2021-2026) & (K Units) Table 46. Global IL-23 Receptor Antagonist Sales Market Share in Volume by Region (2021-2026) Table 47. Global IL-23 Receptor Antagonist Sales by Region (2021-2026) & (US$ Million) Table 48. Global IL-23 Receptor Antagonist Sales Market Share in Value by Region (2021-2026) Table 49. Global IL-23 Receptor Antagonist Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 50. Global IL-23 Receptor Antagonist Sales by Region (2027-2032) & (K Units) Table 51. Global IL-23 Receptor Antagonist Sales Market Share in Volume by Region (2027-2032) Table 52. Global IL-23 Receptor Antagonist Sales by Region (2027-2032) & (US$ Million) Table 53. Global IL-23 Receptor Antagonist Sales Market Share in Value by Region (2027-2032) Table 54. Global IL-23 Receptor Antagonist Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 55. Global IL-23 Receptor Antagonist Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 56. Global IL-23 Receptor Antagonist Sales by Application (2021-2026) & (K Units) Table 57. Global IL-23 Receptor Antagonist Sales Market Share in Volume by Application (2021-2026) Table 58. Global IL-23 Receptor Antagonist Sales by Application (2021-2026) & (US$ Million) Table 59. Global IL-23 Receptor Antagonist Sales Market Share in Value by Application (2021-2026) Table 60. Global IL-23 Receptor Antagonist Price by Application (2021-2026) & (US$/Unit) Table 61. Global IL-23 Receptor Antagonist Sales by Application (2027-2032) & (K Units) Table 62. Global IL-23 Receptor Antagonist Sales Market Share in Volume by Application (2027-2032) Table 63. Global IL-23 Receptor Antagonist Sales by Application (2027-2032) & (US$ Million) Table 64. Global IL-23 Receptor Antagonist Sales Market Share in Value by Application (2027-2032) Table 65. Global IL-23 Receptor Antagonist Price by Application (2027-2032) & (US$/Unit) Table 66. North America IL-23 Receptor Antagonist Sales by Application (2021-2026) & (K Units) Table 67. North America IL-23 Receptor Antagonist Sales by Application (2021-2026) & (US$ Million) Table 68. Europe IL-23 Receptor Antagonist Sales by Application (2021-2026) & (K Units) Table 69. Europe IL-23 Receptor Antagonist Sales by Application (2021-2026) & (US$ Million) Table 70. Asia-Pacific IL-23 Receptor Antagonist Sales by Application (2021-2026) & (K Units) Table 71. Asia-Pacific IL-23 Receptor Antagonist Sales by Application (2021-2026) & (US$ Million) Table 72. Latin America IL-23 Receptor Antagonist Sales by Application (2021-2026) & (K Units) Table 73. Latin America IL-23 Receptor Antagonist Sales by Application (2021-2026) & (US$ Million) Table 74. Middle East and Africa IL-23 Receptor Antagonist Sales by Application (2021-2026) & (K Units) Table 75. Middle East and Africa IL-23 Receptor Antagonist Sales by Application (2021-2026) & (US$ Million) Table 76. Qyuns Therapeutics Company Information Table 77. Qyuns Therapeutics Business Overview Table 78. Qyuns Therapeutics IL-23 Receptor Antagonist Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Qyuns Therapeutics IL-23 Receptor Antagonist Product Portfolio Table 80. Qyuns Therapeutics Recent Development Table 81. China Medical System Company Information Table 82. China Medical System Business Overview Table 83. China Medical System IL-23 Receptor Antagonist Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. China Medical System IL-23 Receptor Antagonist Product Portfolio Table 85. China Medical System Recent Development Table 86. Huadong Medicine Company Information Table 87. Huadong Medicine Business Overview Table 88. Huadong Medicine IL-23 Receptor Antagonist Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Huadong Medicine IL-23 Receptor Antagonist Product Portfolio Table 90. Huadong Medicine Recent Development Table 91. Bio-Thera Solutions Company Information Table 92. Bio-Thera Solutions Business Overview Table 93. Bio-Thera Solutions IL-23 Receptor Antagonist Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. Bio-Thera Solutions IL-23 Receptor Antagonist Product Portfolio Table 95. Bio-Thera Solutions Recent Development Table 96. Teva Company Information Table 97. Teva Business Overview Table 98. Teva IL-23 Receptor Antagonist Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. Teva IL-23 Receptor Antagonist Product Portfolio Table 100. Teva Recent Development Table 101. Sun Pharma Company Information Table 102. Sun Pharma Business Overview Table 103. Sun Pharma IL-23 Receptor Antagonist Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. Sun Pharma IL-23 Receptor Antagonist Product Portfolio Table 105. Sun Pharma Recent Development Table 106. Sandoz Company Information Table 107. Sandoz Business Overview Table 108. Sandoz IL-23 Receptor Antagonist Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 109. Sandoz IL-23 Receptor Antagonist Product Portfolio Table 110. Sandoz Recent Development Table 111. Samsung Bioepis Company Information Table 112. Samsung Bioepis Business Overview Table 113. Samsung Bioepis IL-23 Receptor Antagonist Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 114. Samsung Bioepis IL-23 Receptor Antagonist Product Portfolio Table 115. Samsung Bioepis Recent Development Table 116. Janssen Pharmaceuticals Company Information Table 117. Janssen Pharmaceuticals Business Overview Table 118. Janssen Pharmaceuticals IL-23 Receptor Antagonist Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 119. Janssen Pharmaceuticals IL-23 Receptor Antagonist Product Portfolio Table 120. Janssen Pharmaceuticals Recent Development Table 121. Eli Lilly Company Information Table 122. Eli Lilly Business Overview Table 123. Eli Lilly IL-23 Receptor Antagonist Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 124. Eli Lilly IL-23 Receptor Antagonist Product Portfolio Table 125. Eli Lilly Recent Development Table 126. Celltrion Company Information Table 127. Celltrion Business Overview Table 128. Celltrion IL-23 Receptor Antagonist Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 129. Celltrion IL-23 Receptor Antagonist Product Portfolio Table 130. Celltrion Recent Development Table 131. Biocon Biologics Company Information Table 132. Biocon Biologics Business Overview Table 133. Biocon Biologics IL-23 Receptor Antagonist Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 134. Biocon Biologics IL-23 Receptor Antagonist Product Portfolio Table 135. Biocon Biologics Recent Development Table 136. Amgen Company Information Table 137. Amgen Business Overview Table 138. Amgen IL-23 Receptor Antagonist Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 139. Amgen IL-23 Receptor Antagonist Product Portfolio Table 140. Amgen Recent Development Table 141. Almirall Company Information Table 142. Almirall Business Overview Table 143. Almirall IL-23 Receptor Antagonist Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 144. Almirall IL-23 Receptor Antagonist Product Portfolio Table 145. Almirall Recent Development Table 146. AbbVie Biotechnology Company Information Table 147. AbbVie Biotechnology Business Overview Table 148. AbbVie Biotechnology IL-23 Receptor Antagonist Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 149. AbbVie Biotechnology IL-23 Receptor Antagonist Product Portfolio Table 150. AbbVie Biotechnology Recent Development Table 151. North America IL-23 Receptor Antagonist Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 152. North America IL-23 Receptor Antagonist Sales by Country (2021-2026) & (K Units) Table 153. North America IL-23 Receptor Antagonist Sales Market Share by Country (2021-2026) Table 154. North America IL-23 Receptor Antagonist Sales Forecast by Country (2027-2032) & (K Units) Table 155. North America IL-23 Receptor Antagonist Sales Market Share Forecast by Country (2027-2032) Table 156. North America IL-23 Receptor Antagonist Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 157. North America IL-23 Receptor Antagonist Market Size by Country (2021-2026) & (US$ Million) Table 158. North America IL-23 Receptor Antagonist Market Share by Country (2021-2026) Table 159. North America IL-23 Receptor Antagonist Market Size Forecast by Country (2027-2032) & (US$ Million) Table 160. North America IL-23 Receptor Antagonist Market Share Forecast by Country (2027-2032) Table 161. Europe IL-23 Receptor Antagonist Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 162. Europe IL-23 Receptor Antagonist Sales by Country (2021-2026) & (K Units) Table 163. Europe IL-23 Receptor Antagonist Sales Market Share by Country (2021-2026) Table 164. Europe IL-23 Receptor Antagonist Sales Forecast by Country (2027-2032) & (K Units) Table 165. Europe IL-23 Receptor Antagonist Sales Market Share Forecast by Country (2027-2032) Table 166. Europe IL-23 Receptor Antagonist Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 167. Europe IL-23 Receptor Antagonist Market Size by Country (2021-2026) & (US$ Million) Table 168. Europe IL-23 Receptor Antagonist Market Share by Country (2021-2026) Table 169. Europe IL-23 Receptor Antagonist Market Size Forecast by Country (2027-2032) & (US$ Million) Table 170. Europe IL-23 Receptor Antagonist Market Share Forecast by Country (2027-2032) Table 171. Asia-Pacific IL-23 Receptor Antagonist Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 172. Asia-Pacific IL-23 Receptor Antagonist Sales by Country (2021-2026) & (K Units) Table 173. Asia-Pacific IL-23 Receptor Antagonist Sales Market Share by Country (2021-2026) Table 174. Asia-Pacific IL-23 Receptor Antagonist Sales Forecast by Country (2027-2032) & (K Units) Table 175. Asia-Pacific IL-23 Receptor Antagonist Sales Market Share Forecast by Country (2027-2032) Table 176. Asia-Pacific IL-23 Receptor Antagonist Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 177. Asia-Pacific IL-23 Receptor Antagonist Market Size by Country (2021-2026) & (US$ Million) Table 178. Asia-Pacific IL-23 Receptor Antagonist Market Share by Country (2021-2026) Table 179. Asia-Pacific IL-23 Receptor Antagonist Market Size Forecast by Country (2027-2032) & (US$ Million) Table 180. Asia-Pacific IL-23 Receptor Antagonist Market Share Forecast by Country (2027-2032) Table 181. Latin America IL-23 Receptor Antagonist Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 182. Latin America IL-23 Receptor Antagonist Sales by Country (2021-2026) & (K Units) Table 183. Latin America IL-23 Receptor Antagonist Sales Market Share by Country (2021-2026) Table 184. Latin America IL-23 Receptor Antagonist Sales Forecast by Country (2027-2032) & (K Units) Table 185. Latin America IL-23 Receptor Antagonist Sales Market Share Forecast by Country (2027-2032) Table 186. Latin America IL-23 Receptor Antagonist Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 187. Latin America IL-23 Receptor Antagonist Market Size by Country (2021-2026) & (US$ Million) Table 188. Latin America IL-23 Receptor Antagonist Market Share by Country (2021-2026) Table 189. Latin America IL-23 Receptor Antagonist Market Size Forecast by Country (2027-2032) & (US$ Million) Table 190. Latin America IL-23 Receptor Antagonist Market Share Forecast by Country (2027-2032) Table 191. Middle East and Africa IL-23 Receptor Antagonist Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 192. Middle East and Africa IL-23 Receptor Antagonist Sales by Country (2021-2026) & (K Units) Table 193. Middle East and Africa IL-23 Receptor Antagonist Sales Market Share by Country (2021-2026) Table 194. Middle East and Africa IL-23 Receptor Antagonist Sales Forecast by Country (2027-2032) & (K Units) Table 195. Middle East and Africa IL-23 Receptor Antagonist Sales Market Share Forecast by Country (2027-2032) Table 196. Middle East and Africa IL-23 Receptor Antagonist Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 197. Middle East and Africa IL-23 Receptor Antagonist Market Size by Country (2021-2026) & (US$ Million) Table 198. Middle East and Africa IL-23 Receptor Antagonist Market Share by Country (2021-2026) Table 199. Middle East and Africa IL-23 Receptor Antagonist Market Size Forecast by Country (2027-2032) & (US$ Million) Table 200. Middle East and Africa IL-23 Receptor Antagonist Market Share Forecast by Country (2027-2032) Table 201. Key Raw Materials Table 202. Raw Materials Key Suppliers Table 203. IL-23 Receptor Antagonist Distributors List Table 204. IL-23 Receptor Antagonist Customers List Table 205. Research Programs/Design for This Report Table 206. Authors List of This Report Table 207. Secondary Sources Table 208. Primary Sources List of Figures Figure 1. IL-23 Receptor Antagonist Image Figure 2. Global IL-23 Receptor Antagonist Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global IL-23 Receptor Antagonist Market Size (2021-2032) & (US$ Million) Figure 4. Global IL-23 Receptor Antagonist Sales (2021-2032) & (K Units) Figure 5. Briakinumab Image Figure 6. Global Briakinumab Sales YoY Growth (2021-2032) & (K Units) Figure 7. Guselkumab Image Figure 8. Global Guselkumab Sales YoY Growth (2021-2032) & (K Units) Figure 9. Mirikizumab Image Figure 10. Global Mirikizumab Sales YoY Growth (2021-2032) & (K Units) Figure 11. Risankizumab Image Figure 12. Global Risankizumab Sales YoY Growth (2021-2032) & (K Units) Figure 13. Tildrakizumab Image Figure 14. Global Tildrakizumab Sales YoY Growth (2021-2032) & (K Units) Figure 15. Ustekinumab Image Figure 16. Global Ustekinumab Sales YoY Growth (2021-2032) & (K Units) Figure 17. Other Image Figure 18. Global Other Sales YoY Growth (2021-2032) & (K Units) Figure 19. Global IL-23 Receptor Antagonist Market Size Overview by Type (2021-2032) & (US$ Million) Figure 20. Global IL-23 Receptor Antagonist Market Share by Type 2025 VS 2032 Figure 21. North America IL-23 Receptor Antagonist Sales Market Share in Volume by Type in 2025 Figure 22. North America IL-23 Receptor Antagonist Sales Market Share in Value by Type in 2025 Figure 23. Europe IL-23 Receptor Antagonist Sales Market Share in Volume by Type in 2025 Figure 24. Europe IL-23 Receptor Antagonist Sales Market Share in Value by Type in 2025 Figure 25. Asia-Pacific IL-23 Receptor Antagonist Sales Market Share in Volume by Type in 2025 Figure 26. Asia-Pacific IL-23 Receptor Antagonist Sales Market Share in Value by Type in 2025 Figure 27. Latin America IL-23 Receptor Antagonist Sales Market Share in Volume by Type in 2025 Figure 28. Latin America IL-23 Receptor Antagonist Sales Market Share in Value by Type in 2025 Figure 29. Middle East and Africa IL-23 Receptor Antagonist Sales Market Share in Volume by Type in 2025 Figure 30. Middle East and Africa IL-23 Receptor Antagonist Sales Market Share in Value by Type in 2025 Figure 31. Global Top 5 and 10 IL-23 Receptor Antagonist Players Market Share by Revenue in 2025 Figure 32. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 33. Plaque Psoriasis Image Figure 34. Global Plaque Psoriasis Sales YoY Growth (2021-2032) & (K Units) Figure 35. Crohn's Disease Image Figure 36. Global Crohn's Disease Sales YoY Growth (2021-2032) & (K Units) Figure 37. Psoriatic Arthritis Image Figure 38. Global Psoriatic Arthritis Sales YoY Growth (2021-2032) & (K Units) Figure 39. Other Image Figure 40. Global Other Sales YoY Growth (2021-2032) & (K Units) Figure 41. Global IL-23 Receptor Antagonist Market Size Overview by Application (2021-2032) & (US$ Million) Figure 42. Global IL-23 Receptor Antagonist Market Share by Application 2025 VS 2032 Figure 43. North America IL-23 Receptor Antagonist Sales Market Share in Volume by Application in 2025 Figure 44. North America IL-23 Receptor Antagonist Sales Market Share in Value by Application in 2025 Figure 45. Europe IL-23 Receptor Antagonist Sales Market Share in Volume by Application in 2025 Figure 46. Europe IL-23 Receptor Antagonist Sales Market Share in Value by Application in 2025 Figure 47. Asia-Pacific IL-23 Receptor Antagonist Sales Market Share in Volume by Application in 2025 Figure 48. Asia-Pacific IL-23 Receptor Antagonist Sales Market Share in Value by Application in 2025 Figure 49. Latin America IL-23 Receptor Antagonist Sales Market Share in Volume by Application in 2025 Figure 50. Latin America IL-23 Receptor Antagonist Sales Market Share in Value by Application in 2025 Figure 51. Middle East and Africa IL-23 Receptor Antagonist Sales Market Share in Volume by Application in 2025 Figure 52. Middle East and Africa IL-23 Receptor Antagonist Sales Market Share in Value by Application in 2025 Figure 53. North America IL-23 Receptor Antagonist Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 54. North America IL-23 Receptor Antagonist Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. North America IL-23 Receptor Antagonist Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. North America IL-23 Receptor Antagonist Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Europe IL-23 Receptor Antagonist Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 58. Europe IL-23 Receptor Antagonist Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe IL-23 Receptor Antagonist Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Europe IL-23 Receptor Antagonist Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific IL-23 Receptor Antagonist Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 62. Asia-Pacific IL-23 Receptor Antagonist Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Asia-Pacific IL-23 Receptor Antagonist Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Asia-Pacific IL-23 Receptor Antagonist Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. Latin America IL-23 Receptor Antagonist Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 66. Latin America IL-23 Receptor Antagonist Sales Share by Country: 2021 VS 2025 VS 2032 Figure 67. Latin America IL-23 Receptor Antagonist Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 68. Latin America IL-23 Receptor Antagonist Market Share by Country: 2021 VS 2025 VS 2032 Figure 69. Middle East and Africa IL-23 Receptor Antagonist Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 70. Middle East and Africa IL-23 Receptor Antagonist Sales Share by Country: 2021 VS 2025 VS 2032 Figure 71. Middle East and Africa IL-23 Receptor Antagonist Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 72. Middle East and Africa IL-23 Receptor Antagonist Market Share by Country: 2021 VS 2025 VS 2032 Figure 73. IL-23 Receptor Antagonist Value Chain Figure 74. Key Raw Materials Price Figure 75. Manufacturing Cost Structure Figure 76. IL-23 Receptor Antagonist Production Mode & Process Figure 77. Direct Comparison with Distribution Share Figure 78. Distributors Profiles Figure 79. Years Considered Figure 80. Research Process Figure 81. Key Executives Interviewed

Scope & coverage.

Types
  • Briakinumab
  • Guselkumab
  • Mirikizumab
  • Risankizumab
  • Tildrakizumab
  • Ustekinumab
  • Other
Applications
  • Plaque Psoriasis
  • Crohn's Disease
  • Psoriatic Arthritis
  • Other
Companies covered
  • Qyuns Therapeutics
  • China Medical System
  • Huadong Medicine
  • Bio-Thera Solutions
  • Teva
  • Sun Pharma
  • Sandoz
  • Samsung Bioepis
  • Janssen Pharmaceuticals
  • Eli Lilly
  • Celltrion
  • Biocon Biologics
  • Amgen
  • Almirall
  • AbbVie Biotechnology

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global IL-23 Receptor Antagonist Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global IL-23 Receptor Antagonist Sales Estimates and Forecasts (2021-2032)
  5. 1.3 IL-23 Receptor Antagonist Market by Type
  6. 1.3.1 Briakinumab
  7. 1.3.2 Guselkumab
  8. 1.3.3 Mirikizumab
  9. 1.3.4 Risankizumab
  10. 1.3.5 Tildrakizumab
  11. 1.3.6 Ustekinumab
  12. 1.3.7 Other
  13. 1.4 Global IL-23 Receptor Antagonist Market Size by Type
  14. 1.4.1 Global IL-23 Receptor Antagonist Market Size Overview by Type (2021-2032)
  15. 1.4.2 Global IL-23 Receptor Antagonist Historic Market Size Review by Type (2021-2026)
  16. 1.4.3 Global IL-23 Receptor Antagonist Forecasted Market Size by Type (2027-2032)
  17. 1.5 Key Regions Market Size by Type
  18. 1.5.1 North America IL-23 Receptor Antagonist Sales Breakdown by Type (2021-2026)
  19. 1.5.2 Europe IL-23 Receptor Antagonist Sales Breakdown by Type (2021-2026)
  20. 1.5.3 Asia-Pacific IL-23 Receptor Antagonist Sales Breakdown by Type (2021-2026)
  21. 1.5.4 South America IL-23 Receptor Antagonist Sales Breakdown by Type (2021-2026)
  22. 1.5.5 Middle East and Africa IL-23 Receptor Antagonist Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 IL-23 Receptor Antagonist Industry Trends
  2. 2.2 IL-23 Receptor Antagonist Industry Drivers
  3. 2.3 IL-23 Receptor Antagonist Industry Opportunities and Challenges
  4. 2.4 IL-23 Receptor Antagonist Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by IL-23 Receptor Antagonist Revenue (2021-2026)
  2. 3.2 Global Top Players by IL-23 Receptor Antagonist Sales (2021-2026)
  3. 3.3 Global Top Players by IL-23 Receptor Antagonist Price (2021-2026)
  4. 3.4 Global IL-23 Receptor Antagonist Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global IL-23 Receptor Antagonist Major Company Production Sites & Headquarters
  6. 3.6 Global IL-23 Receptor Antagonist Company, Product Type & Application
  7. 3.7 Global IL-23 Receptor Antagonist Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global IL-23 Receptor Antagonist Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 IL-23 Receptor Antagonist Players Market Share by Revenue in 2025
  11. 3.8.3 2025 IL-23 Receptor Antagonist Tier 1, Tier 2, and Tier 3
4 IL-23 Receptor Antagonist Regional Status and Outlook
  1. 4.1 Global IL-23 Receptor Antagonist Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global IL-23 Receptor Antagonist Historic Market Size by Region
  3. 4.2.1 Global IL-23 Receptor Antagonist Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global IL-23 Receptor Antagonist Sales in Value by Region (2021-2026)
  5. 4.2.3 Global IL-23 Receptor Antagonist Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global IL-23 Receptor Antagonist Forecasted Market Size by Region
  7. 4.3.1 Global IL-23 Receptor Antagonist Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global IL-23 Receptor Antagonist Sales in Value by Region (2027-2032)
  9. 4.3.3 Global IL-23 Receptor Antagonist Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 IL-23 Receptor Antagonist by Application
  1. 5.1 IL-23 Receptor Antagonist Market by Application
  2. 5.1.1 Plaque Psoriasis
  3. 5.1.2 Crohn's Disease
  4. 5.1.3 Psoriatic Arthritis
  5. 5.1.4 Other
  6. 5.2 Global IL-23 Receptor Antagonist Market Size by Application
  7. 5.2.1 Global IL-23 Receptor Antagonist Market Size Overview by Application (2021-2032)
  8. 5.2.2 Global IL-23 Receptor Antagonist Historic Market Size Review by Application (2021-2026)
  9. 5.2.3 Global IL-23 Receptor Antagonist Forecasted Market Size by Application (2027-2032)
  10. 5.3 Key Regions Market Size by Application
  11. 5.3.1 North America IL-23 Receptor Antagonist Sales Breakdown by Application (2021-2026)
  12. 5.3.2 Europe IL-23 Receptor Antagonist Sales Breakdown by Application (2021-2026)
  13. 5.3.3 Asia-Pacific IL-23 Receptor Antagonist Sales Breakdown by Application (2021-2026)
  14. 5.3.4 South America IL-23 Receptor Antagonist Sales Breakdown by Application (2021-2026)
  15. 5.3.5 Middle East and Africa IL-23 Receptor Antagonist Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Qyuns Therapeutics
  2. 6.1.1 Qyuns Therapeutics Company Information
  3. 6.1.2 Qyuns Therapeutics Business Overview
  4. 6.1.3 Qyuns Therapeutics IL-23 Receptor Antagonist Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Qyuns Therapeutics IL-23 Receptor Antagonist Product Portfolio
  6. 6.1.5 Qyuns Therapeutics Recent Developments
  7. 6.2 China Medical System
  8. 6.2.1 China Medical System Company Information
  9. 6.2.2 China Medical System Business Overview
  10. 6.2.3 China Medical System IL-23 Receptor Antagonist Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 China Medical System IL-23 Receptor Antagonist Product Portfolio
  12. 6.2.5 China Medical System Recent Developments
  13. 6.3 Huadong Medicine
  14. 6.3.1 Huadong Medicine Company Information
  15. 6.3.2 Huadong Medicine Business Overview
  16. 6.3.3 Huadong Medicine IL-23 Receptor Antagonist Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Huadong Medicine IL-23 Receptor Antagonist Product Portfolio
  18. 6.3.5 Huadong Medicine Recent Developments
  19. 6.4 Bio-Thera Solutions
  20. 6.4.1 Bio-Thera Solutions Company Information
  21. 6.4.2 Bio-Thera Solutions Business Overview
  22. 6.4.3 Bio-Thera Solutions IL-23 Receptor Antagonist Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Bio-Thera Solutions IL-23 Receptor Antagonist Product Portfolio
  24. 6.4.5 Bio-Thera Solutions Recent Developments
  25. 6.5 Teva
  26. 6.5.1 Teva Company Information
  27. 6.5.2 Teva Business Overview
  28. 6.5.3 Teva IL-23 Receptor Antagonist Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Teva IL-23 Receptor Antagonist Product Portfolio
  30. 6.5.5 Teva Recent Developments
  31. 6.6 Sun Pharma
  32. 6.6.1 Sun Pharma Company Information
  33. 6.6.2 Sun Pharma Business Overview
  34. 6.6.3 Sun Pharma IL-23 Receptor Antagonist Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Sun Pharma IL-23 Receptor Antagonist Product Portfolio
  36. 6.6.5 Sun Pharma Recent Developments
  37. 6.7 Sandoz
  38. 6.7.1 Sandoz Company Information
  39. 6.7.2 Sandoz Business Overview
  40. 6.7.3 Sandoz IL-23 Receptor Antagonist Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Sandoz IL-23 Receptor Antagonist Product Portfolio
  42. 6.7.5 Sandoz Recent Developments
  43. 6.8 Samsung Bioepis
  44. 6.8.1 Samsung Bioepis Company Information
  45. 6.8.2 Samsung Bioepis Business Overview
  46. 6.8.3 Samsung Bioepis IL-23 Receptor Antagonist Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Samsung Bioepis IL-23 Receptor Antagonist Product Portfolio
  48. 6.8.5 Samsung Bioepis Recent Developments
  49. 6.9 Janssen Pharmaceuticals
  50. 6.9.1 Janssen Pharmaceuticals Company Information
  51. 6.9.2 Janssen Pharmaceuticals Business Overview
  52. 6.9.3 Janssen Pharmaceuticals IL-23 Receptor Antagonist Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Janssen Pharmaceuticals IL-23 Receptor Antagonist Product Portfolio
  54. 6.9.5 Janssen Pharmaceuticals Recent Developments
  55. 6.10 Eli Lilly
  56. 6.10.1 Eli Lilly Company Information
  57. 6.10.2 Eli Lilly Business Overview
  58. 6.10.3 Eli Lilly IL-23 Receptor Antagonist Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Eli Lilly IL-23 Receptor Antagonist Product Portfolio
  60. 6.10.5 Eli Lilly Recent Developments
  61. 6.11 Celltrion
  62. 6.11.1 Celltrion Company Information
  63. 6.11.2 Celltrion Business Overview
  64. 6.11.3 Celltrion IL-23 Receptor Antagonist Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Celltrion IL-23 Receptor Antagonist Product Portfolio
  66. 6.11.5 Celltrion Recent Developments
  67. 6.12 Biocon Biologics
  68. 6.12.1 Biocon Biologics Company Information
  69. 6.12.2 Biocon Biologics Business Overview
  70. 6.12.3 Biocon Biologics IL-23 Receptor Antagonist Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Biocon Biologics IL-23 Receptor Antagonist Product Portfolio
  72. 6.12.5 Biocon Biologics Recent Developments
  73. 6.13 Amgen
  74. 6.13.1 Amgen Company Information
  75. 6.13.2 Amgen Business Overview
  76. 6.13.3 Amgen IL-23 Receptor Antagonist Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Amgen IL-23 Receptor Antagonist Product Portfolio
  78. 6.13.5 Amgen Recent Developments
  79. 6.14 Almirall
  80. 6.14.1 Almirall Company Information
  81. 6.14.2 Almirall Business Overview
  82. 6.14.3 Almirall IL-23 Receptor Antagonist Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 Almirall IL-23 Receptor Antagonist Product Portfolio
  84. 6.14.5 Almirall Recent Developments
  85. 6.15 AbbVie Biotechnology
  86. 6.15.1 AbbVie Biotechnology Company Information
  87. 6.15.2 AbbVie Biotechnology Business Overview
  88. 6.15.3 AbbVie Biotechnology IL-23 Receptor Antagonist Sales, Revenue and Gross Margin (2021-2026)
  89. 6.15.4 AbbVie Biotechnology IL-23 Receptor Antagonist Product Portfolio
  90. 6.15.5 AbbVie Biotechnology Recent Developments
7 North America by Country
  1. 7.1 North America IL-23 Receptor Antagonist Sales by Country
  2. 7.1.1 North America IL-23 Receptor Antagonist Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America IL-23 Receptor Antagonist Sales by Country (2021-2026)
  4. 7.1.3 North America IL-23 Receptor Antagonist Sales Forecast by Country (2027-2032)
  5. 7.2 North America IL-23 Receptor Antagonist Market Size by Country
  6. 7.2.1 North America IL-23 Receptor Antagonist Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America IL-23 Receptor Antagonist Market Size by Country (2021-2026)
  8. 7.2.3 North America IL-23 Receptor Antagonist Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe IL-23 Receptor Antagonist Sales by Country
  2. 8.1.1 Europe IL-23 Receptor Antagonist Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe IL-23 Receptor Antagonist Sales by Country (2021-2026)
  4. 8.1.3 Europe IL-23 Receptor Antagonist Sales Forecast by Country (2027-2032)
  5. 8.2 Europe IL-23 Receptor Antagonist Market Size by Country
  6. 8.2.1 Europe IL-23 Receptor Antagonist Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe IL-23 Receptor Antagonist Market Size by Country (2021-2026)
  8. 8.2.3 Europe IL-23 Receptor Antagonist Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific IL-23 Receptor Antagonist Sales by Country
  2. 9.1.1 Asia-Pacific IL-23 Receptor Antagonist Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific IL-23 Receptor Antagonist Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific IL-23 Receptor Antagonist Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific IL-23 Receptor Antagonist Market Size by Country
  6. 9.2.1 Asia-Pacific IL-23 Receptor Antagonist Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific IL-23 Receptor Antagonist Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific IL-23 Receptor Antagonist Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America IL-23 Receptor Antagonist Sales by Country
  2. 10.1.1 South America IL-23 Receptor Antagonist Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America IL-23 Receptor Antagonist Sales by Country (2021-2026)
  4. 10.1.3 South America IL-23 Receptor Antagonist Sales Forecast by Country (2027-2032)
  5. 10.2 South America IL-23 Receptor Antagonist Market Size by Country
  6. 10.2.1 South America IL-23 Receptor Antagonist Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America IL-23 Receptor Antagonist Market Size by Country (2021-2026)
  8. 10.2.3 South America IL-23 Receptor Antagonist Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa IL-23 Receptor Antagonist Sales by Country
  2. 11.1.1 Middle East and Africa IL-23 Receptor Antagonist Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa IL-23 Receptor Antagonist Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa IL-23 Receptor Antagonist Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa IL-23 Receptor Antagonist Market Size by Country
  6. 11.2.1 Middle East and Africa IL-23 Receptor Antagonist Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa IL-23 Receptor Antagonist Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa IL-23 Receptor Antagonist Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 IL-23 Receptor Antagonist Value Chain Analysis
  2. 12.1.1 IL-23 Receptor Antagonist Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 IL-23 Receptor Antagonist Production Mode & Process
  7. 12.2 IL-23 Receptor Antagonist Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 IL-23 Receptor Antagonist Distributors
  10. 12.2.3 IL-23 Receptor Antagonist Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst